VVOS
Vivos Therapeutics, Inc. (NASDAQ)
Healthcare — Medical Devices
Vivos Therapeutics, Inc. operates as a medical technology and healthcare services company that develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children. It markets and sells its appliances, and related treatments and services to licensed professionals, primarily general dentists in the United States and Canada. The company was formerly known as Vivos BioTechnologies, Inc. and changed its name to Vivos Therapeutics, Inc. in March 2018. The company was founded in 2016 and is based in Littleton, Colorado.
Price History
Fundamentals
| Market Cap | $6.75M |
| P/E Ratio (TTM) | - |
| Forward P/E | -0.58 |
| EPS (TTM) | $-2.14 |
| Dividend Yield | - |
| Profit Margin | -127.70% |
| Revenue Growth | 70.50% |
| ROE | -1599.81% |
| Debt/Equity | - |
| Recommendation | None |
| Analyst Target | $2.45 |
| Analysts | 3 |
| Indexes | NASDAQ |
Technical Indicators
| RSI (14) | 36.4 |
| Beta | 6.08 |
| SMA 20 | - |
| SMA 40 | - |
| 52-Week High | $7.95 |
| 52-Week Low | $0.38 |
| 50-Day Avg | $0.66 |
| 200-Day Avg | $1.73 |
| Avg Volume | $1.75M |
| Volume | 30.1K |
Performance Analysis
NEUTRALVVOS presents a mixed picture with both positive and negative indicators.
Recent News
Last updated: Jul 02, 2026 13:37 UTC
Back to Screener Export Report